Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum
暂无分享,去创建一个
C. Rogier | B. Pradines | D. Malvy | P. Parola | F. Simon | F. Benoit‐Vical | D. Maubon | S. Picot | P. Delaunay | C. Oeuvray | D. Basset | B. Faugère | Eric Didillon | G. Ménard | Aurélie Pascual | Nathalie Bourgeois